Lung Cancer Webinars

Bringing experiences together



The life-saving potential of early lung cancer detection1 is increasingly recognized, and individual countries have already started to implement screening programs. What can we learn from these countries?

Target group: Medical (e.g., radiologists, pulmonologists, and other referral and specialty physicians) and policy stakeholders

Agenda

  • General considerations: Steps towards the implementation of lung cancer screening programs at European level (Dr. Sebastian Schmidt, Head of CT Strategy, Innovation & Medical Affairs at Siemens Healthineers)
  • Lung cancer screening in the UK: Experiences and insights in a trailer-based program (Professor Richard Booton2 PhD FRCP, Consultant Respiratory Physician, Honorary MAHSC Clinical Professor & Clinical Director, Directorate of Lung Cancer & Thoracic Surgery, North West Lung Centre, Wythenshawe Hospital, Manchester, UK)
  • Lung cancer screening in Poland: Organizational program set-up (Joanna Bidzińska2, Ph.D., EMBA, Project coordinator of National Lung Cancer Screening in the University Clinical Centre in Gdańsk for the northern Macroregion of Poland)
  • Q&A

Learning Objectives

  • Why is lung cancer screening a critical factor in reducing lung cancer mortality?
  • What is the status of lung cancer screening programs in the EU?
  • How can a screening program be implemented?
  • What are possible approaches on how to set up a lung cancer screening program?
  • What are the lessons or pitfalls?



At ECR 2022, we held our lunch symposium titled "Lung cancer screening and its role in radiology practice", which was very well received.

Agenda

  • Experience with the implementation of LCS in Poland: How Poland set up their lung cancer screening program, Radiologist and lung cancer screening. Polish experience (Prof. Witold Rzyman2, Gdansk / Poland)
  • CT Technologies for Lung Cancer Screening: Which technology parameters are important to achieve good quality images at ultra low dose, what needs to be considered in finding your local LCS protocol (Prof. Dr. Marc Kachelrieß2, Heidelberg / Germany)
  • The role of Artificial Intelligence (AI) in a LCS Program: Identifying smoking-related disease on LCS CT scans, the role of AI in LCS (Prof. Philippe Grenier2, Suresnes, France)
  • Q&A
2